{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:56:22Z","timestamp":1792180582655,"version":"4.4.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.pnpbp.2023.110848","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T05:12:08Z","timestamp":1692940328000},"page":"110848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence"],"prefix":"10.1016","volume":"128","author":[{"given":"Meysam","family":"Amidfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ku","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1750-3639.2010.00449.x","article-title":"Oleic acid ameliorates amyloidosis in cellular and mouse models of Alzheimer\u2019s disease","volume":"21","author":"Amtul","year":"2011","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-2012-112138","article-title":"Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer\u2019s disease","volume":"31","author":"Arlt","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.pnpbp.2023.110848_bb0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jagp.2019.01.214","article-title":"Metabolic syndrome, mild cognitive impairment, and dementia: a meta-analysis of longitudinal studies","volume":"27","author":"Atti","year":"2019","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110848_bb0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0025","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/156720512799015064","article-title":"Metabolic dysfunction in Alzheimer\u2019s disease and related neurodegenerative disorders","volume":"9","author":"Cai","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2023.110848_bb0035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/ars.2016.6768","article-title":"Metabolic syndrome as a risk factor for Alzheimer\u2019s disease: is A\u03b2 a crucial factor in both pathologies?","volume":"26","author":"Campos-Pena","year":"2017","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/18715273113129990103","article-title":"Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?","volume":"13","author":"Caraci","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.14336\/AD.2014.002","article-title":"Metabolic risk factors of sporadic Alzheimer\u2019s disease: implications in the pathology, pathogenesis and treatment","volume":"6","author":"Chakrabarti","year":"2015","journal-title":"Aging Dis."},{"issue":"s1","key":"10.1016\/j.pnpbp.2023.110848_bb0050","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.3233\/JAD-179911","article-title":"Metabolic dysfunction in Alzheimer\u2019s disease: from basic neurobiology to clinical approaches","volume":"64","author":"Clarke","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/026010600601800307","article-title":"Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Cole","year":"2006","journal-title":"Nutr. Health"},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3945\/jn.109.113910","article-title":"DHA may prevent age-related dementia","volume":"140","author":"Cole","year":"2010","journal-title":"J. Nutr."},{"issue":"5123","key":"10.1016\/j.pnpbp.2023.110848_bb0065","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged","volume":"66","author":"Craft","year":"2009","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.pnpbp.2023.110848_bb0080","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/NEN.0000000000000116","article-title":"Lysophosphatidylcholine and amide as metabolites for detecting Alzheimer disease using ultrahigh-performance liquid chromatography\u2013quadrupole time-of-flight mass spectrometry\u2013based metabonomics","volume":"73","author":"Cui","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110848_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.plipres.2009.04.001","article-title":"Fish, docosahexaenoic acid and Alzheimer\u2019s disease","volume":"48","author":"Cunnane","year":"2009","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0090","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2012-110629","article-title":"Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer\u2019s disease","volume":"29","author":"Cunnane","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0095","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(04)00710-0","article-title":"Amnestic MCI or prodromal Alzheimer's disease?","volume":"3","author":"Dubois","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bioelechem.2016.11.003","article-title":"Alzheimer's disease amyloid beta peptides in vitro electrochemical oxidation","volume":"114","author":"Enache","year":"2017","journal-title":"Bioelectrochemistry"},{"issue":"16","key":"10.1016\/j.pnpbp.2023.110848_bb0110","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.pnpbp.2023.110848_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-94-010-0448-0_11","article-title":"Metabolomics\u2014the link between genotypes and phenotypes","author":"Fiehn","year":"2002","journal-title":"Funct. Genom."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0120","doi-asserted-by":"crossref","first-page":"13764","DOI":"10.1038\/s41598-019-50205-0","article-title":"Targeted metabolomic analysis of nitric oxide\/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes","volume":"9","author":"Fleszar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer\u2019s disease subjects","volume":"32","author":"Fonteh","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.pnpbp.2023.110848_bb0130","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fnins.2018.01027","article-title":"The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer\u2019s disease","volume":"12","author":"Forny-Germano","year":"2019","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.arr.2010.04.007","article-title":"Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer\u2019s disease","volume":"9","author":"Frisardi","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpba.2014.05.023","article-title":"Metabolomic study of lipids in serum for biomarker discovery in Alzheimer\u2019s disease using direct infusion mass spectrometry","volume":"98","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","article-title":"Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer\u2019s disease by direct infusion mass spectrometry","volume":"102","author":"Gonzalez-Dominguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.pnpbp.2023.110848_bb0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1567205013666160129095138","article-title":"Metabolomic-driven elucidation of serum disturbances associated with Alzheimer\u2019s disease and mild cognitive impairment","volume":"13","author":"Gonzalez-Dominguez","year":"2016","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119452","article-title":"Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer\u2019s disease","volume":"10","author":"Graham","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2023.110848_bb0160","first-page":"838","article-title":"Fruit flies, bile acids, and Parkinson disease: a mitochondrial connection?","author":"Greenamyre","year":"2015","journal-title":"AAN Enterprises"},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0165","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/elps.200800589","article-title":"A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease","volume":"30","author":"Greenberg","year":"2009","journal-title":"Electrophoresis"},{"issue":"11","key":"10.1016\/j.pnpbp.2023.110848_bb0170","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ncb1313","article-title":"Regulation of cholesterol and sphingomyelin metabolism by amyloid-\u03b2 and presenilin","volume":"7","author":"Grimm","year":"2005","journal-title":"Nat. Cell Biol."},{"issue":"42","key":"10.1016\/j.pnpbp.2023.110848_bb0175","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1016\/j.chroma.2011.07.073","article-title":"From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin\u2013plasmalogens derivates in Alzheimer\u2019s disease human post mortem brains and mice model via mass spectrometry","volume":"1218","author":"Grimm","year":"2011","journal-title":"J. Chromatogr. A"},{"issue":"16","key":"10.1016\/j.pnpbp.2023.110848_bb0180","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1074\/jbc.M110.182329","article-title":"Docosahexaenoic acid reduces amyloid \u03b2 production via multiple pleiotropic mechanisms","volume":"286","author":"Grimm","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0185","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","article-title":"Alzheimer\u2019s disease: amino acid levels and brain metabolic status","volume":"34","author":"Gueli","year":"2013","journal-title":"Neurol. Sci."},{"issue":"8","key":"10.1016\/j.pnpbp.2023.110848_bb0190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbalip.2010.01.010","article-title":"Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease","volume":"1801","author":"Han","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2012-120022","article-title":"Urinary homocysteic acid levels correlate with mini-mental state examination scores in Alzheimer\u2019s disease patients","volume":"31","author":"Hasegawa","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110848_bb0205","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1471-4159.2002.00905.x","article-title":"Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer\u2019s disease model rats","volume":"81","author":"Hashimoto","year":"2002","journal-title":"J. Neurochem."},{"issue":"Supplement","key":"10.1016\/j.pnpbp.2023.110848_bb0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1515\/REVNEURO.2000.11.S1.213","article-title":"A unifying hypothesis of Alzheimer\u2019s disease. IV. Causation and sequence of events","volume":"11","author":"Heininger","year":"2000","journal-title":"Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0215","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2015-2315","article-title":"Cognitive effects of intentional weight loss in elderly obese individuals with mild cognitive impairment","volume":"101","author":"Horie","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0220","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1038\/srep02364","article-title":"Metabolic profiling of Alzheimer\u2019s disease brains","volume":"3","author":"Inoue","year":"2013","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ddr.21579","article-title":"Cognitive dysfunction: A growing link between diabetes and Alzheimer\u2019s disease","volume":"81","author":"Jash","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnins.2019.00343","article-title":"Metabolomics in the development and progression of dementia: a systematic review","volume":"13","author":"Jiang","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0235","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2008.174","article-title":"Metabolomics: a global biochemical approach to the study of central nervous system diseases","volume":"34","author":"Kaddurah-Daouk","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0240","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/tp.2013.18","article-title":"Alterations in metabolic pathways and networks in Alzheimer\u2019s disease","volume":"3","author":"Kaddurah-Daouk","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1474-4422(10)70277-5","article-title":"Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease","volume":"10","author":"Kapogiannis","year":"2011","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(14)70085-7","article-title":"Adipokines: a link between obesity and dementia?","volume":"13","author":"Kiliaan","year":"2014","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0255","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1038\/emm.2015.3","article-title":"Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome","volume":"47","author":"Kim","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2023.110848_bb0260","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jalz.2019.03.004","article-title":"Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European medical information framework for Alzheimer\u2019s disease biomarker discovery cohort","volume":"15","author":"Kim","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-022-01107-3","article-title":"Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology","volume":"14","author":"Kim","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0270","series-title":"Mayo Clinic Proceedings","first-page":"1452","article-title":"Mild cognitive impairment and mild dementia: a clinical perspective","author":"Knopman","year":"2014"},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI0216127","article-title":"The therapeutic potential of modulating the ceramide\/sphingomyelin pathway","volume":"110","author":"Kolesnick","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0280","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.pnpbp.2023.110848_bb0285","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.clinbiochem.2010.04.072","article-title":"Plasma metabolic profiling of Alzheimer\u2019s disease by liquid chromatography\/mass spectrometry","volume":"43","author":"Li","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer\u2019s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146554","article-title":"Elevated serum TC and LDL-C levels in Alzheimer\u2019s disease and mild cognitive impairment: A meta-analysis study","volume":"1727","author":"Liu","year":"2020","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0300","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.numecd.2009.12.007","article-title":"Olive oil and health: summary of the II international conference on olive oil and health consensus report, Ja\u00e9n and C\u00f3rdoba (Spain) 2008","volume":"20","author":"L\u00f3pez-Miranda","year":"2010","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0305","article-title":"A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia","volume":"12","author":"Ma","year":"2020","journal-title":"Alzheimer's & Dementia Diagnosis Assessment Dis. Monitor."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0310","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease\u2014an emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"14","key":"10.1016\/j.pnpbp.2023.110848_bb0315","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1073\/pnas.0912955107","article-title":"\u201cControl\u201d laboratory rodents are metabolically morbid: why it matters","volume":"107","author":"Martin","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0320","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12603-013-0027-6","article-title":"Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial","volume":"17","author":"Martinez-Lapiscina","year":"2013","journal-title":"J. Nutr. Health Aging"},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0325","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/biom12071001","article-title":"Comparison of tau and amyloid-\u03b2 targeted immunotherapy nanoparticles for Alzheimer\u2019s disease","volume":"12","author":"Mashal","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.pnpbp.2023.110848_bb0330","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/jnnp.2005.063388","article-title":"Lipid lowering agents are associated with a slower cognitive decline in Alzheimer\u2019s disease","volume":"76","author":"Masse","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0335","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tem.2010.05.005","article-title":"Alzheimer's disease: brain expression of a metabolic disorder?","volume":"21","author":"Merlo","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0345","series-title":"Mechanisms of Dietary Restriction in Aging and Disease","author":"Mobbs","year":"2007"},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bib601","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.60.7.940","article-title":"Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease","volume":"60","author":"Morris","year":"2003","journal-title":"Archives of neurology"},{"key":"10.1016\/j.pnpbp.2023.110848_bb0350","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer\u2019s disease: methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi","year":"2013","journal-title":"Clin. Transl. Imaging"},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0355","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1046\/j.1460-9568.2003.02999.x","article-title":"Retrosplenial cortex (BA 29\/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer\u2019s disease)","volume":"18","author":"Nestor","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0360","doi-asserted-by":"crossref","first-page":"e197978","DOI":"10.1001\/jamanetworkopen.2019.7978","article-title":"Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers","volume":"2","author":"Nho","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0365","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","article-title":"Altered bile acid profile in mild cognitive impairment and Alzheimer\u2019s disease: relationship to neuroimaging and CSF biomarkers","volume":"15","author":"Nho","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0370","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/acn3.50956","article-title":"High-resolution metabolomic profiling of Alzheimer\u2019s disease in plasma","volume":"7","author":"Niedzwiecki","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0375","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hbm.22173","article-title":"Covarying alterations in A\u03b2 deposition, glucose metabolism, and gray matter volume in cognitively normal elderly","volume":"35","author":"Oh","year":"2014","journal-title":"Hum. Brain Mapp."},{"issue":"8","key":"10.1016\/j.pnpbp.2023.110848_bb0380","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/brain\/aww108","article-title":"Dynamic relationships between age, amyloid-\u03b2 deposition, and glucose metabolism link to the regional vulnerability to Alzheimer\u2019s disease","volume":"139","author":"Oh","year":"2016","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.pnpbp.2023.110848_bb0385","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer\u2019s disease","volume":"1","author":"Ore\u0161i\u010d","year":"2011","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2023.110848_bb0390","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/cercor\/bht076","article-title":"Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?","volume":"24","author":"Ossenkoppele","year":"2014","journal-title":"Cereb. Cortex"},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0395","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology","volume":"61","author":"Pappolla","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0400","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1471-4159.2008.05454.x","article-title":"Metabolic syndrome and the role of dietary lifestyles in Alzheimer\u2019s disease","volume":"106","author":"Pasinetti","year":"2008","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0410","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jalz.2015.06.1888","article-title":"Mediterranean diet and preserved brain structural connectivity in older subjects","volume":"11","author":"Pelletier","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0415","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.phrs.2018.07.013","article-title":"Activities, bioavailability, and metabolism of lipids from structural membranes and oils: promising research on mild cognitive impairment","volume":"134","author":"Perez-Galvez","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0420","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0425","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11011-021-00673-z","article-title":"Metabolic disorder in Alzheimer\u2019s disease","volume":"36","author":"Poddar","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0430","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0435","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer\u2019s disease: A comprehensive lipidomics analysis","volume":"13","author":"Proitsi","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"17","key":"10.1016\/j.pnpbp.2023.110848_bib602","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0440","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2009.02.019","article-title":"Metabolomics tools for identifying biomarkers for neuropsychiatric diseases","volume":"35","author":"Quinones","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.pnpbp.2023.110848_bb0445","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3390\/ijms21062010","article-title":"Adiponectin and cognitive decline","volume":"21","author":"Rizzo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0450","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cger.2013.07.003","article-title":"Classification and epidemiology of MCI","volume":"29","author":"Roberts","year":"2013","journal-title":"Clin. Geriatr. Med."},{"issue":"19","key":"10.1016\/j.pnpbp.2023.110848_bb0455","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/elps.201100139","article-title":"Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease","volume":"32","author":"Samakashvili","year":"2011","journal-title":"Electrophoresis"},{"issue":"11","key":"10.1016\/j.pnpbp.2023.110848_bb0460","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/nn.2213","article-title":"Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Sanchez-Mejia","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"23","key":"10.1016\/j.pnpbp.2023.110848_bb0465","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1021\/ac102211r","article-title":"Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography\/mass spectrometry","volume":"82","author":"Sato","year":"2010","journal-title":"Anal. Chem."},{"issue":"11","key":"10.1016\/j.pnpbp.2023.110848_bb0470","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","article-title":"Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham heart study","volume":"63","author":"Schaefer","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0475","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.arr.2005.02.003","article-title":"Glucose metabolism and Alzheimer\u2019s disease","volume":"4","author":"Schubert","year":"2005","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0480","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/0271678X15611678","article-title":"Blood metabolite markers of cognitive performance and brain function in aging","volume":"36","author":"Simpson","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110848_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002266","article-title":"Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study","volume":"14","author":"Snowden","year":"2017","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110848_bb0490","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4875","article-title":"Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC\/MS","volume":"34","author":"Sun","year":"2020","journal-title":"Biomed. Chromatogr."},{"issue":"8","key":"10.1016\/j.pnpbp.2023.110848_bb0500","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2009.42.8.475","article-title":"Insulin resistance and Alzheimer\u2019s disease","volume":"42","author":"Suzanne","year":"2009","journal-title":"BMB Rep."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0505","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u2019s disease","volume":"88","author":"Suzanne","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/an.111.000893","article-title":"Omega-3 fatty acids EPA and DHA: health benefits throughout life","volume":"3","author":"Swanson","year":"2012","journal-title":"Adv. Nutr."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0515","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3940(91)90542-2","article-title":"A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson\u2019s disease and spinocerebellar degeneration","volume":"126","author":"Tohgi","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0520","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map","volume":"13","author":"Toledo","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0525","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00394-019-02126-x","article-title":"Polyunsaturated fatty acids and risk of Alzheimer\u2019s disease: a Mendelian randomization study","volume":"59","author":"Tomata","year":"2020","journal-title":"Eur. J. Nutr."},{"issue":"8","key":"10.1016\/j.pnpbp.2023.110848_bb0530","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of metabolomics to Alzheimer\u2019s disease","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110848_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.pnpbp.2023.110848_bb0540","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1021\/acs.chemrestox.6b00179","article-title":"Computational metabolomics: a framework for the million metabolome","volume":"29","author":"Uppal","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"7","key":"10.1016\/j.pnpbp.2023.110848_bb0545","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamainternmed.2015.1668","article-title":"Mediterranean diet and age-related cognitive decline: a randomized clinical trial","volume":"175","author":"Valls-Pedret","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110848_bb0555","doi-asserted-by":"crossref","first-page":"14059","DOI":"10.1038\/s41598-020-70703-w","article-title":"Peripheral serum metabolomic profiles inform central cognitive impairment","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0560","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fneur.2019.01223","article-title":"The differences of serum metabolites between patients with early-stage Alzheimer\u2019s disease and mild cognitive impairment","volume":"10","author":"Weng","year":"2019","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110848_bb0565","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"7504","key":"10.1016\/j.pnpbp.2023.110848_bb0570","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","article-title":"Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study","volume":"330","author":"Whitmer","year":"2005","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110848_bb0575","doi-asserted-by":"crossref","first-page":"701","DOI":"10.14283\/jpad.2022.54","article-title":"Obesity and brain health: the impact of metabolic syndrome and cardiorespiratory fitness on cognitive performances in middle-aged obese women","volume":"9","author":"Wichayanrat","year":"2022","journal-title":"J. Prevent. Alzheimer\u2019s Dis."},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110848_bb0580","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12802","article-title":"Aging and Alzheimer\u2019s disease: comparison and associations from molecular to system level","volume":"17","author":"Xia","year":"2018","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.pnpbp.2023.110848_bb0585","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbadis.2016.03.001","article-title":"Graded perturbations of metabolism in multiple regions of human brain in Alzheimer\u2019s disease: snapshot of a pervasive metabolic disorder","volume":"1862","author":"Xu","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110848_bb0590","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/metabo10090357","article-title":"Targeted metabolic profiling of urine highlights a potential biomarker panel for the diagnosis of Alzheimer\u2019s disease and mild cognitive impairment: a pilot study","volume":"10","author":"Yilmaz","year":"2020","journal-title":"Metabolites"},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2023.110848_bb0595","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0736-5748(00)00013-7","article-title":"Essential fatty acids and the brain: possible health implications","volume":"18","author":"Youdim","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.pnpbp.2023.110848_bb0600","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnagi.2019.00090","article-title":"Dysregulated urinary arginine metabolism in older adults with amnestic mild cognitive impairment","volume":"11","author":"Zhang","year":"2019","journal-title":"Front. Aging Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584623001343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584623001343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:02:41Z","timestamp":1759521761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584623001343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":122,"alternative-id":["S0278584623001343"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110848","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110848"}}